2019 was a banner year for the biotech industry which is was brimming with innovation and growth, especially within the BioHealth Capital Region (BHCR). From Kite Pharma’s announcement of its new state-of-the-art cell manufacturing facility in Frederick County, Maryland, and the opening of the 32,000 square foot JLABS @ Washington, D.C. to Viela Bio’s $150M IPO and Paragon Bioservices $1.2B acquisition by Catalent, 2019 was an exciting year for so many companies and people in the region.
Image: https://biobuzz.io/
